Ertugliflozin

Description

What is Ertugliflozin?

Ertugliflozin belongs to the class of potent and selective inhibitors of the sodium-dependent glucose cotransporters (SGLT), more specifically the type 2 which is responsible for about 90% of the glucose reabsorption from glomerulus. This drug was developed under the collaboration of Merck and Pfizer. It was FDA approved as monotherapy and in combination with sitagliptin or metformin hydrochloride on December 22, 2017.

Basic information

Product Name:	Ertugliflozin
Synonyms:	Steglatro; Ertugliflozin INN;
CAS:	1210344-57-2
MF:	C22H25ClO7
MW:	436.88
Product Categories:	API

Chemical Structure

Ertugliflozin

Chemical Properties

Boiling point	630.5±55.0 °C(Predicted)
density	1.455
storage temp.	Sealed in dry,Store in freezer, under -20°C
pka	12.95±0.70(Predicted)

What Maxmadchem do

Maxmedchem, a global supplier of Ertugliflozin , 1210344-57-2 offers for your requirements of RND / Development quantities or commercials, based on status of the product. We can also offer lots of intermediates with supportive technical package required for evaluation.

a) Free sample can be supplied.

b) Guide our clients by professional knowledge and teach them how to use our product after sales.

c) Accept SGS,BV any other third-party inspection before loading.

d) High quality best price Guaranteed.

Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

MSDS: MSDS available.

COA: COA can be available if you send us inquiry.

Email us at: info@maxmedchem.com for more details.